Literature DB >> 18496552

Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure.

H-H Li1, Y-H Hsu, C-C Wei, P-T Lee, W-C Chen, M-S Chang.   

Abstract

Acute renal failure is an abrupt decrease in renal function. Interleukin (IL)-10 inhibits ischemic and cisplatin-induced acute renal failure. We aimed to determine whether IL-20 affects renal tubular epithelial cells and is associated with acute renal failure. We analyzed the expression of IL-20 and its receptor (R) in the kidneys of rats with HgCl(2)-induced acute renal failure. Reverse transcription-PCR showed upregulated IL-20, and its receptors and immunohistochemical staining showed strongly expressed IL-20 protein in proximal tubular epithelial cells. We analyzed human proximal tubular epithelial (HK-2) cells, which expressed both IL-20 and its receptors. IL-20 specifically induced mitochondria-dependent apoptosis by activating caspase 9 in HK-2 cells. IL-20 also activated c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2, the downstream signals implicated in the apoptosis of HK-2 cells. Furthermore, IL-20 upregulated the transcripts of transforming growth factor (TGF)-beta1, a critical mediator of renal injury. In hypoxic HK-2 cells, IL-20 and IL-22R1 transcripts increased, and IL-20 upregulated IL-1 beta transcripts. In vivo study further demonstrated that anti-IL-20 antibody reduced the expression of TGF-beta1 and IL-1 beta and the number of damaged tubular cells in the kidneys of rats with acute renal failure. We concluded that IL-20 may be involved in the injury of renal epithelial cells in acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496552     DOI: 10.1038/gene.2008.28

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  16 in total

1.  IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation.

Authors:  Yu-Hsiang Hsu; Chih-Hsing Wu; Chiao-Juno Chiu; Wei-Ting Chen; Yi-Chieh Chang; Martin Wabitsch; Ming-Shi Chang
Journal:  Immunology       Date:  2021-08-30       Impact factor: 7.397

2.  Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss.

Authors:  Yu-Hsiang Hsu; Wei-Yu Chen; Chien-Hui Chan; Chih-Hsing Wu; Zih-Jie Sun; Ming-Shi Chang
Journal:  J Exp Med       Date:  2011-08-15       Impact factor: 14.307

Review 3.  Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family.

Authors:  Erna Sziksz; Domonkos Pap; Rita Lippai; Nóra Judit Béres; Andrea Fekete; Attila J Szabó; Ádám Vannay
Journal:  Mediators Inflamm       Date:  2015-06-24       Impact factor: 4.711

4.  Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis.

Authors:  Yu-Hsiang Hsu; Ya-Yu Yang; Man-Hsiang Huwang; Yun-Han Weng; I-Ming Jou; Po-Tin Wu; Tain-Yu Lin; Li-Wha Wu; Ming-Shi Chang
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy.

Authors:  Yu-Hsiang Hsu; Hsing-Hui Li; Junne-Ming Sung; Wei-Yu Chen; Ya-Chin Hou; Yun-Han Weng; Wei-Ting Lai; Chih-Hsing Wu; Ming-Shi Chang
Journal:  Exp Mol Med       Date:  2017-03-31       Impact factor: 8.718

6.  Anti-IL-20 antibody improved motor function and reduced glial scar formation after traumatic spinal cord injury in rats.

Authors:  Jung-Shun Lee; Yu-Hsiang Hsu; Yi-Shu Chiu; I-Ming Jou; Ming-Shi Chang
Journal:  J Neuroinflammation       Date:  2020-05-14       Impact factor: 8.322

7.  Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases.

Authors:  Anna Ónody; Apor Veres-Székely; Domonkos Pap; Réka Rokonay; Beáta Szebeni; Erna Sziksz; Franz Oswald; Gábor Veres; Áron Cseh; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

8.  Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury.

Authors:  Yu-Hsiang Hsu; Hsing-Hui Li; Junne-Ming Sung; Wei-Ting Chen; Ya-Chin Hou; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

Review 9.  IL-20 bone diseases involvement and therapeutic target potential.

Authors:  Hsiao-Hsuan Wang; Yu-Hsiang Hsu; Ming-Shi Chang
Journal:  J Biomed Sci       Date:  2018-04-24       Impact factor: 8.410

10.  Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Réka Rokonay; Anna Ónody; Rita Lippai; István Márton Takács; András Tislér; Magdolna Kardos; Franz Oswald; Andrea Fekete; Attila J Szabó; Ádám Vannay
Journal:  J Transl Med       Date:  2020-04-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.